![](/img/cover-not-exists.png)
750 PRECLINICAL PHARMACOKINETIC PROFILE OF IDX320, A NOVEL AND POTENT HCV PROTEASE INHIBITOR
S.S. Good, X.-R. Pan-Zhou, M. Larsson, S. Luo, J.R. Selden, H. Rashidzadeh, S. Bhadresa, M. Camire, C. Parsy, D. SurlerauxVolume:
52
Year:
2010
Language:
english
DOI:
10.1016/s0168-8278(10)60752-0
File:
PDF, 46 KB
english, 2010